{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,6,3]],"date-time":"2026-06-03T15:24:03Z","timestamp":1780500243459,"version":"3.54.1"},"reference-count":26,"publisher":"Elsevier BV","issue":"3","license":[{"start":{"date-parts":[[2013,2,1]],"date-time":"2013-02-01T00:00:00Z","timestamp":1359676800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2013,2,1]],"date-time":"2013-02-01T00:00:00Z","timestamp":1359676800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"}],"content-domain":{"domain":["elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Clinical Biochemistry"],"published-print":{"date-parts":[[2013,2]]},"DOI":"10.1016\/j.clinbiochem.2012.11.004","type":"journal-article","created":{"date-parts":[[2012,11,13]],"date-time":"2012-11-13T05:57:33Z","timestamp":1352786253000},"page":"225-229","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":65,"title":["Diagnostic accuracy of soluble urokinase plasminogen activator receptor (suPAR) for prediction of bacteremia in patients with systemic inflammatory response syndrome"],"prefix":"10.1016","volume":"46","author":[{"given":"Martin","family":"Hoenigl","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Reinhard B.","family":"Raggam","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jasmin","family":"Wagner","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Thomas","family":"Valentin","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Eva","family":"Leitner","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Katharina","family":"Seeber","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Ines","family":"Zollner-Schwetz","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Werner","family":"Krammer","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Florian","family":"Pr\u00fcller","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Andrea J.","family":"Grisold","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Robert","family":"Krause","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"key":"10.1016\/j.clinbiochem.2012.11.004_bb0005","doi-asserted-by":"crossref","first-page":"1644","DOI":"10.1378\/chest.101.6.1644","article-title":"Definitions for sepsis and organ failure and guidelines for the use of innovative therapies in sepsis. The ACCP\/SCCM Consensus Conference Committee. American College of Chest Physicians\/Society of Critical Care Medicine","volume":"101","author":"Bone","year":"1992","journal-title":"Chest"},{"key":"10.1016\/j.clinbiochem.2012.11.004_bb0010","doi-asserted-by":"crossref","first-page":"2964","DOI":"10.1128\/JCM.00418-07","article-title":"Prospective comparison of eubacterial PCR and measurement of procalcitonin levels with blood culture for diagnosing septicemia in intensive care unit patients","volume":"47","author":"Rowther","year":"2009","journal-title":"J Clin Microbiol"},{"key":"10.1016\/j.clinbiochem.2012.11.004_bb0015","doi-asserted-by":"crossref","first-page":"R38","DOI":"10.1186\/cc5723","volume":"11","author":"Kofoed","year":"2007","journal-title":"Crit Care"},{"key":"10.1016\/j.clinbiochem.2012.11.004_bb0020","doi-asserted-by":"crossref","first-page":"157","DOI":"10.1155\/2009\/504294","article-title":"suPAR: the molecular crystal ball","volume":"27","author":"Thuno","year":"2009","journal-title":"Dis Markers"},{"key":"10.1016\/j.clinbiochem.2012.11.004_bb0025","doi-asserted-by":"crossref","first-page":"209","DOI":"10.1016\/j.jcv.2010.11.014","article-title":"The diagnostic and prognostic significance of soluble urokinase plasminogen activator receptor in Crimean-Congo hemorrhagic fever","volume":"50","author":"Yilmaz","year":"2011","journal-title":"J Clin Virol"},{"key":"10.1016\/j.clinbiochem.2012.11.004_bb0030","doi-asserted-by":"crossref","first-page":"55","DOI":"10.1016\/j.jinf.2008.01.014","article-title":"suPAR associates to glucose metabolic aberration during glucose stimulation in HIV-infected patients on HAART","volume":"57","author":"Andersen","year":"2008","journal-title":"J Infect"},{"issue":"6","key":"10.1016\/j.clinbiochem.2012.11.004_bb0035","doi-asserted-by":"crossref","first-page":"374","DOI":"10.1007\/s10753-010-9195-2","article-title":"Urine suPAR levels compared with plasma suPAR Levels as Predictors of post-consultation mortality risk among individuals assumed to be TB-negative: a prospective cohort study","volume":"33","author":"Rabna","year":"2010","journal-title":"Inflammation"},{"key":"10.1016\/j.clinbiochem.2012.11.004_bb0040","doi-asserted-by":"crossref","first-page":"207","DOI":"10.1111\/j.0141-9838.2004.00695.x","article-title":"Serum levels of soluble urokinase plasminogen activator receptor is associated with parasitemia in children with acute Plasmodium falciparum malaria infection","volume":"26","author":"Perch","year":"2004","journal-title":"Parasite Immunol"},{"key":"10.1016\/j.clinbiochem.2012.11.004_bb0045","first-page":"1","article-title":"Soluble urokinase plasminogen activator receptor (suPAR) in the assessment of inflammatory activity of rheumatoid arthritis patients in remission","author":"Toldi","year":"2012","journal-title":"Clin Chem Lab Med"},{"key":"10.1016\/j.clinbiochem.2012.11.004_bb0050","first-page":"717","article-title":"Presence of urokinase-type plasminogen activator receptor in urine of cancer patients and its possible clinical relevance","volume":"79","author":"Sier","year":"1999","journal-title":"Lab Invest"},{"key":"10.1016\/j.clinbiochem.2012.11.004_bb0055","doi-asserted-by":"crossref","first-page":"233","DOI":"10.1177\/172460080101600402","article-title":"Soluble urokinase plasminogen activator receptor measurements: influence of sample handling","volume":"16","author":"Riisbro","year":"2001","journal-title":"Int J Biol Markers"},{"key":"10.1016\/j.clinbiochem.2012.11.004_bb0060","doi-asserted-by":"crossref","first-page":"409","DOI":"10.1111\/j.1469-0691.2004.00850.x","article-title":"The plasma level of soluble urokinase receptor is elevated in patients with Streptococcus pneumoniae bacteraemia and predicts mortality","volume":"10","author":"Wittenhagen","year":"2004","journal-title":"Clin Microbiol Infect"},{"key":"10.1016\/j.clinbiochem.2012.11.004_bb0065","doi-asserted-by":"crossref","first-page":"32","DOI":"10.1111\/j.1365-2796.2011.02363.x","article-title":"Plasma level of soluble urokinase-type plasminogen activator receptor as a predictor of disease severity and case fatality in patients with bacteraemia: a prospective cohort study","volume":"270","author":"Huttunen","year":"2011","journal-title":"J Intern Med"},{"key":"10.1016\/j.clinbiochem.2012.11.004_bb0070","doi-asserted-by":"crossref","first-page":"1417","DOI":"10.1007\/s10096-011-1236-8","article-title":"Elevated soluble urokinase plasminogen activator receptor (suPAR) predicts mortality in Staphylococcus aureus bacteremia","volume":"30","author":"Molkanen","year":"2011","journal-title":"Eur J Clin Microbiol Infect Dis"},{"key":"10.1016\/j.clinbiochem.2012.11.004_bb0075","doi-asserted-by":"crossref","first-page":"1227","DOI":"10.1016\/j.clinbiochem.2011.07.006","article-title":"The diagnostic and prognostic significance of soluble urokinase plasminogen activator receptor in systemic inflammatory response syndrome","volume":"44","author":"Yilmaz","year":"2011","journal-title":"Clin Biochem"},{"key":"10.1016\/j.clinbiochem.2012.11.004_bb0080","doi-asserted-by":"crossref","first-page":"108","DOI":"10.1007\/s00134-001-1143-z","article-title":"Epidemiology of sepsis and infection in ICU patients from an international multicentre cohort study","volume":"28","author":"Alberti","year":"2002","journal-title":"Intensive Care Med"},{"key":"10.1016\/j.clinbiochem.2012.11.004_bb0085","first-page":"e28","article-title":"Definitions for sepsis and organ failure and guidelines for the use of innovative therapies in sepsis. The ACCP\/SCCM Consensus Conference Committee. American College of Chest Physicians\/Society of Critical Care Medicine. 1992","volume":"136","author":"Bone","year":"2009","journal-title":"Chest"},{"key":"10.1016\/j.clinbiochem.2012.11.004_bb0090","doi-asserted-by":"crossref","first-page":"766","DOI":"10.1373\/clinchem.2006.077180","article-title":"Expressing the modification of diet in renal disease study equation for estimating glomerular filtration rate with standardized serum creatinine values","volume":"53","author":"Levey","year":"2007","journal-title":"Clin Chem"},{"key":"10.1016\/j.clinbiochem.2012.11.004_bb0095","doi-asserted-by":"crossref","first-page":"2561","DOI":"10.1097\/01.CCM.0000239120.32490.AB","article-title":"Macrophage serum markers in pneumococcal bacteremia: prediction of survival by soluble CD163","volume":"34","author":"Moller","year":"2006","journal-title":"Crit Care Med"},{"key":"10.1016\/j.clinbiochem.2012.11.004_bb0100","doi-asserted-by":"crossref","first-page":"R63","DOI":"10.1186\/cc10037","article-title":"Circulating soluble urokinase plasminogen activator receptor is stably elevated during the first week of treatment in the intensive care unit and predicts mortality in critically ill patients","volume":"15","author":"Koch","year":"2011","journal-title":"Crit Care"},{"key":"10.1016\/j.clinbiochem.2012.11.004_bb0105","doi-asserted-by":"crossref","first-page":"1020","DOI":"10.1186\/cc10577","article-title":"Why high suPAR is not super - diagnostic, prognostic and potential pathogenic properties of a novel biomarker in the ICU","volume":"15","author":"Koch","year":"2011","journal-title":"Crit Care"},{"key":"10.1016\/j.clinbiochem.2012.11.004_bb0110","doi-asserted-by":"crossref","first-page":"2","DOI":"10.1186\/1741-7015-10-2","article-title":"suPAR as a prognostic biomarker in sepsis","volume":"10","author":"Donadello","year":"2012","journal-title":"BMC Med"},{"key":"10.1016\/j.clinbiochem.2012.11.004_bb0115","doi-asserted-by":"crossref","first-page":"375","DOI":"10.1007\/s10096-007-0447-5","article-title":"Predicting mortality in patients with systemic inflammatory response syndrome: an evaluation of two prognostic models, two soluble receptors, and a macrophage migration inhibitory factor","volume":"27","author":"Kofoed","year":"2008","journal-title":"Eur J Clin Microbiol Infect Dis"},{"key":"10.1016\/j.clinbiochem.2012.11.004_bb0120","series-title":"The Inter99 Study","article-title":"Influence of Lifestyle on suPAR Levels","author":"Pisinger","year":"2012"},{"key":"10.1016\/j.clinbiochem.2012.11.004_bb0125","doi-asserted-by":"crossref","first-page":"296","DOI":"10.1111\/j.1365-2796.2010.02252.x","article-title":"Circulating soluble urokinase plasminogen activator receptor predicts cancer, cardiovascular disease, diabetes and mortality in the general population","volume":"268","author":"Eugen-Olsen","year":"2010","journal-title":"J Intern Med"},{"issue":"4","key":"10.1016\/j.clinbiochem.2012.11.004_bb0130","doi-asserted-by":"crossref","first-page":"479","DOI":"10.1111\/j.1464-5491.2011.03513.x","article-title":"The immune marker soluble urokinase plasminogen activator receptor is associated with new-onset diabetes in non-smoking women and men","volume":"29","author":"Haugaard","year":"2012","journal-title":"Diabet Med"}],"container-title":["Clinical Biochemistry"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0009912012006212?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0009912012006212?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2025,9,14]],"date-time":"2025-09-14T15:38:37Z","timestamp":1757864317000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0009912012006212"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2013,2]]},"references-count":26,"journal-issue":{"issue":"3","published-print":{"date-parts":[[2013,2]]}},"alternative-id":["S0009912012006212"],"URL":"https:\/\/doi.org\/10.1016\/j.clinbiochem.2012.11.004","relation":{},"ISSN":["0009-9120"],"issn-type":[{"value":"0009-9120","type":"print"}],"subject":[],"published":{"date-parts":[[2013,2]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Diagnostic accuracy of soluble urokinase plasminogen activator receptor (suPAR) for prediction of bacteremia in patients with systemic inflammatory response syndrome","name":"articletitle","label":"Article Title"},{"value":"Clinical Biochemistry","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.clinbiochem.2012.11.004","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"Copyright \u00a9 2012 The Canadian Society of Clinical Chemists. Published by Elsevier Inc. All rights reserved.","name":"copyright","label":"Copyright"}]}}